Sat, Jul 4, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Estimize announces data licensing agreement with Bloomberg

Thursday, April 18, 2013

Bailey McCann, Opalesque New York: Estimize, the buy side and independent analyst earnings estimates platform, today announced a licensing agreement with Bloomberg to feature Estimize’s earnings data on more than 900 publicly traded stocks via the Bloomberg Professional service’s news and research feeds. Opalesque recently interviewed Estimize CEO, Leigh Drogen about the company which seeks to open up earnings estimates and provide analysis not driven by sell-side incentives.

Estimize claims that its estimates are 67% more accurate than their sell-side cohorts. The company said in a statement today that the agreement with Bloomberg further validates this claim. The accuracy is driven by the diverse range of analysts contributing on Estimize, comprised of hedge fund, institutional buy-side, independent research and individual investors. Drogen, himself, was a former hedge fund quantitative analyst, and wants to improve upon the inherently conflicted estimates produced by the sell-side.

"The Bloomberg community consists of more than 300,000 financial professionals and we’re thrilled to be a part of that community as a data provider. In addition to validating the philosophy behind our process and accuracy of our earnings data, we believe the licensing agreement with Bloomberg will help drive an amazing set of new contributors to our platform, furth......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner